MTCH
40
-10
GIS
34
-3
AVB
57
2
JNJ
35
-6
EMC
77
6
AME
54
-5
WYNN
32
2
CVS
36
-8
PPG
60
-4
GOOG
87
6
CINF
31
2
IR
58
-2
INTU
62
5
DOW
36
-2
TAP
61
-3
ESS
59
2
HBI
52
4
AKAM
61
3
DD
55
2
AVY
51
-2
MTCH
40
-10
GIS
34
-3
AVB
57
2
JNJ
35
-6
EMC
77
6
AME
54
-5
WYNN
32
2
CVS
36
-8
PPG
60
-4
GOOG
87
6
CINF
31
2
IR
58
-2
INTU
62
5
DOW
36
-2
TAP
61
-3
ESS
59
2
HBI
52
4
AKAM
61
3
DD
55
2
AVY
51
-2
Financhill
Back

Invesco NASDAQ 100 ETF CADH Vs. Aligos Therapeutics Industry Stock Comparison

Buy
81

QQC.F.TO
Invesco NASDAQ 100 ETF CADH

Last Price:
172.39
Seasonality Move:
4.47%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
34.48
Seasonality Move:
10.65%
Buy
81
Invesco NASDAQ 100 ETF CADH (QQC.F.TO) is a Buy

Is Invesco NASDAQ 100 ETF CADH a Buy, Sell or Hold?

  • The current Invesco NASDAQ 100 ETF CADH [QQC.F.TO] share price is $172.39. The Score for QQC.F.TO is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
  • QQC.F.TO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

QQC.F.TO Stock Price Chart

What is Invesco NASDAQ 100 ETF CADH's stock price today?

  • The Invesco NASDAQ 100 ETF CADH share price today is $172.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QQC.F.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

QQC.F.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 68.48 Buy
Chaikin Money Flow: 1040 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (164.01 - 169.39) Buy
Bollinger Bands (100): (151.7 - 164.88) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

QQC.F.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 169.92 Buy
20-day SMA: 166.6 Buy
50-day SMA: 163.44 Buy
200-day SMA: 153.52 Buy
8-day EMA: 169.74 Buy
20-day EMA: 167.44 Buy
50-day EMA: 163.9 Buy
200-day EMA: 153.11 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

Invesco NASDAQ 100 ETF CADH Earnings Growth & QQC.F.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Invesco NASDAQ 100 ETF CADH Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):